Karo Bio and Pfizer Form Research Collaboration to Discover and Develop ROR-Gamma Modulators

By Heather Cartwright

Pharma Deals Review: Vol 2012 Issue 1 (Table of Contents)

Published: 18 Jan-2012

DOI: 10.3833/pdr.v2012.i1.1671     ISSN: 1756-7874

Section: Research & Development



After announcing its intention to spin-off its preclinical activities in October 2011, Swedish biotech Karo Bio has formed a research collaboration with Pfizer to advance its ROR-gamma (retinoic acid-related orphan receptor gamma) drug discovery programme for autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and psoriasis...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details